- Conditions
- Survivors of Unilateral Retinoblastoma
- Interventions
- BASC-3 survey, PROMIS survey
- Behavioral
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 8 Years to 17 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2026
- U.S. locations
- 2
- States / cities
- New York, New York • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Sep 2, 2025 · Synced May 21, 2026, 6:20 PM EDT